Vaccine Ontology
15383 terms(s) returned
| Term Type: | Record: 14001 to 14050 of 15383 Records | Page: 281 of 308, First Previous Next Last | Show Records Per Page |
- pcm from Yersinia pestis
- pending final vetting
- peptide
- peptide vaccine
- peptide vaccine role
- percutaneous route
- percutaneous vaccination
- period of persistence of vaccine induced immune response
- peripheral nervous system disease
- peripheral nervous system neoplasm
- peritoneum
- persistence of vaccine induced immune response
- personal neoantigen cancer vaccine
- personalized follicular lymphoma vaccine
- personalized mature dendritic cell vaccine
- personalized neoantigen melanoma vaccine
- persons aged 25--64 years with medical conditions at higher risk for influenza-related complications
- persons aged 6 months--24 years
- persons living with or providing care for infants aged <6 months
- pertussis
- pertussis vaccine 0.0468 MG/ML
- pertussis vaccine 0.0468 MG/ML Injectable Solution
- pertussis vaccine 600 UNT/ML Injectable Solution
- pertussis vaccine 8 UNT/ML
- pertussis vaccine 8 UNT/ML Injectable Solution
- pgk from B. abortus
- pgm from B. abortus
- pgp.LAMP-1 DNA vaccine plasmid
- phCMV1 DNA vaccine plasmid
- phagocyte
- phagocyte (sensu Vertebrata)
- pharyngeal mucosal route
- pharyngeal mucosal vaccination
- pharynx cancer
- phase 1 vaccine trial
- phase 2 vaccine trial
- phase 3 vaccine trial
- phase 4 vaccine trial
- phenol
- phenol vaccine preservative
- phenoxy ethanol vaccine preservative
- phoP
- phoP from Mycobacterium tuberculosis
- phoP from Salmonella Typhi
- phoP from Yersinia pseudotuberculosis
- phosphate buffered saline solution
- phpA-79
- physical object quality
- physical quality
- pig vaccine
